GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Deferred Tax

Center Laboratories (ROCO:4123) Deferred Tax : NT$0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Center Laboratories's change in deferred tax for the three months ended in Mar. 2024 was NT$0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0 Mil.

Center Laboratories Deferred Tax Historical Data

The historical data trend for Center Laboratories's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories Deferred Tax Chart

Center Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Center Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Center Laboratories Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Center Laboratories Deferred Tax Related Terms

Thank you for viewing the detailed overview of Center Laboratories's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Center Laboratories (ROCO:4123) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Deferred Tax
Comparable Companies
TPE:1707 TPE:1789 ROCO:4105 ROCO:6620 ROCO:4114 TPE:3705 ROCO:6785 ROCO:6576 TPE:1720 TPE:4746 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Website
https://www.centerlab.com.tw
Center Laboratories Inc is active in the healthcare sector. The company provides solutions to special medication needs of infants, young children, the elderly, patients with dysphagia and special population. In addition to the diversification of new formulations of oral solution, Center Laboratories is dedicated to new drug development of CNS and pain treatment.

Center Laboratories (ROCO:4123) Headlines

No Headlines